Login / Signup
Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia.
David J Kuter
Published in:
Journal of internal medicine (2023)
Keyphrases
</>
metastatic colorectal cancer
drug induced